Literature DB >> 9521701

Mammalian DNA topoisomerase I activity and poisoning by camptothecin are inhibited by simian virus 40 large T antigen.

Y Pommier1, G Kohlhagen, C Wu, D T Simmons.   

Abstract

DNA topoisomerase I (top1) is a ubiquitous enzyme that forms reversible DNA single-strand breaks (cleavage complexes) and plays a role in transcription, DNA replication, and repair. Top1 is the target of camptothecins which selectively trap top1 cleavage complexes and represent a novel class of anticancer drugs active against human solid tumors. The present study demonstrates that recombinant large T antigen (T-Ag), a virus encoded helicase with strong affinity for tumor suppressors and cell cycle- and replication-related proteins, suppresses top1 cleavage complexes and top1 catalytic activity. This top1 suppressive activity is probably not due to T-Ag binding to DNA, as a T-Ag truncation mutant containing only the first 246 amino acids and deficient in DNA binding also inhibited top1, and the inhibition was independent of ATP. T-Ag also antagonized and reversed the trapping of top1 cleavage complexes by camptothecin. These results demonstrate a functional interaction between T-Ag and top1: they also suggest the importance of top1-protein interactions for the regulation of DNA replication and modulation of camptothecin activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9521701     DOI: 10.1021/bi972067d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Poisoning of human DNA topoisomerase I by ecteinascidin 743, an anticancer drug that selectively alkylates DNA in the minor groove.

Authors:  Y Takebayashi; P Pourquier; A Yoshida; G Kohlhagen; Y Pommier
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

2.  Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5'-phosphorylated DNA double-strand breaks by replication runoff.

Authors:  D Strumberg; A A Pilon; M Smith; R Hickey; L Malkas; Y Pommier
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

3.  Potential protein partners for the N-terminal domain of human topoisomerase I revealed by phage display.

Authors:  Agata M Trzcińska; Agnieszka Girstun; Agnieszka Piekiełko; Barbara Kowalska-Loth; Krzysztof Staroń
Journal:  Mol Biol Rep       Date:  2002-12       Impact factor: 2.316

Review 4.  Repair of topoisomerase I-mediated DNA damage.

Authors:  Yves Pommier; Juana M Barcelo; V Ashutosh Rao; Olivier Sordet; Andrew G Jobson; Laurent Thibaut; Ze-Hong Miao; Jennifer A Seiler; Hongliang Zhang; Christophe Marchand; Keli Agama; John L Nitiss; Christophe Redon
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

5.  Transcriptional consequences of topoisomerase inhibition.

Authors:  I Collins; A Weber; D Levens
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

6.  Human topoisomerase I promotes initiation of simian virus 40 DNA replication in vitro.

Authors:  P W Trowbridge; R Roy; D T Simmons
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

7.  Simian virus 40 DNA replication is dependent on an interaction between topoisomerase I and the C-terminal end of T antigen.

Authors:  Sujata Khopde; Daniel T Simmons
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

8.  Nucleolin inhibits G4 oligonucleotide unwinding by Werner helicase.

Authors:  Fred E Indig; Ivana Rybanska; Parimal Karmakar; Chakravarty Devulapalli; Haiqing Fu; France Carrier; Vilhelm A Bohr
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

Review 9.  Roles of eukaryotic topoisomerases in transcription, replication and genomic stability.

Authors:  Yves Pommier; Yilun Sun; Shar-Yin N Huang; John L Nitiss
Journal:  Nat Rev Mol Cell Biol       Date:  2016-09-21       Impact factor: 113.915

10.  Characterization of BTBD1 and BTBD2, two similar BTB-domain-containing Kelch-like proteins that interact with Topoisomerase I.

Authors:  Lixin Xu; Lihong Yang; Keiko Hashimoto; Melvin Anderson; Glenda Kohlhagen; Yves Pommier; Peter D'Arpa
Journal:  BMC Genomics       Date:  2002-01-07       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.